Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Social Support in Fear Extinction
NCT04166071Phase 1Enrolling by invitation
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Naltrexone with Placebo (2 arms). Primary endpoints: Fear Response directly post-extinction at 0 hours and Fear Response 24-hours post-extinction. Started Dec 2021; status: enrolling by invitation.
02
Drugs
naltrexone
Beyond the preview
Go deeper on NCT04166071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04166071.